Global Connected Injectable Drug Delivery Devices Market Research Report 2019

Table of Contents

Executive Summary

1 Connected Injectable Drug Delivery Devices Market Overview

• 1.1 Product Overview and Scope of Connected Injectable Drug Delivery Devices
• 1.2 Connected Injectable Drug Delivery Devices Segment by Type
  • 1.2.1 Global Connected Injectable Drug Delivery Devices Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Conventional
  • 1.2.3 Self-Injection
  • 1.2.4 Others
• 1.3 Connected Injectable Drug Delivery Devices Segment by Application
  • 1.3.1 Connected Injectable Drug Delivery Devices Consumption Comparison by Application (2014-2025)
  • 1.3.2 Diabetes
  • 1.3.3 Cardiovascular Diseases
  • 1.3.4 Autoimmune Diseases
  • 1.3.5 Hormones Replacement
  • 1.3.6 Neurology
  • 1.3.7 Addiction
  • 1.3.8 Respiratory Diseases
  • 1.3.9 Others
• 1.3 Global Connected Injectable Drug Delivery Devices Market by Region
  • 1.3.1 Global Connected Injectable Drug Delivery Devices Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Connected Injectable Drug Delivery Devices Market Size
  • 1.4.1 Global Connected Injectable Drug Delivery Devices Revenue (2014-2025)
  • 1.4.2 Global Connected Injectable Drug Delivery Devices Production (2014-2025)

2 Global Connected Injectable Drug Delivery Devices Market Competition by Manufacturers

• 2.1 Global Connected Injectable Drug Delivery Devices Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Connected Injectable Drug Delivery Devices Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Connected Injectable Drug Delivery Devices Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Connected Injectable Drug Delivery Devices Production Sites, Area Served, Product Types
• 2.5 Connected Injectable Drug Delivery Devices Market Competitive Situation and Trends
  • 2.5.1 Connected Injectable Drug Delivery Devices Market Concentration Rate
  • 2.5.2 Connected Injectable Drug Delivery Devices Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Connected Injectable Drug Delivery Devices Production Market Share by Regions

• 3.1 Global Connected Injectable Drug Delivery Devices Production Market Share by Regions
• 3.2 Global Connected Injectable Drug Delivery Devices Revenue Market Share by Regions (2014-2019)
• 3.3 Global Connected Injectable Drug Delivery Devices Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Connected Injectable Drug Delivery Devices Production
  • 3.4.1 North America Connected Injectable Drug Delivery Devices Production Growth Rate (2014-2019)
  • 3.4.2 North America Connected Injectable Drug Delivery Devices Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Connected Injectable Drug Delivery Devices Production
  • 3.5.1 Europe Connected Injectable Drug Delivery Devices Production Growth Rate (2014-2019)
  • 3.5.2 Europe Connected Injectable Drug Delivery Devices Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Connected Injectable Drug Delivery Devices Production (2014-2019)
  • 3.6.1 China Connected Injectable Drug Delivery Devices Production Growth Rate (2014-2019)
  • 3.6.2 China Connected Injectable Drug Delivery Devices Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Connected Injectable Drug Delivery Devices Production (2014-2019)
  • 3.7.1 Japan Connected Injectable Drug Delivery Devices Production Growth Rate (2014-2019)
  • 3.7.2 Japan Connected Injectable Drug Delivery Devices Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Connected Injectable Drug Delivery Devices Consumption by Regions

• 4.1 Global Connected Injectable Drug Delivery Devices Consumption by Regions
• 4.2 North America Connected Injectable Drug Delivery Devices Consumption (2014-2019)
• 4.3 Europe Connected Injectable Drug Delivery Devices Consumption (2014-2019)
• 4.4 China Connected Injectable Drug Delivery Devices Consumption (2014-2019)
• 4.5 Japan Connected Injectable Drug Delivery Devices Consumption (2014-2019)

5 Global Connected Injectable Drug Delivery Devices Production, Revenue, Price Trend by Type

• 5.1 Global Connected Injectable Drug Delivery Devices Production Market Share by Type (2014-2019)
• 5.2 Global Connected Injectable Drug Delivery Devices Revenue Market Share by Type (2014-2019)
• 5.3 Global Connected Injectable Drug Delivery Devices Price by Type (2014-2019)
• 5.4 Global Connected Injectable Drug Delivery Devices Production Growth by Type (2014-2019)

6 Global Connected Injectable Drug Delivery Devices Market Analysis by Applications

• 6.1 Global Connected Injectable Drug Delivery Devices Consumption Market Share by Application (2014-2019)
• 6.2 Global Connected Injectable Drug Delivery Devices Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Connected Injectable Drug Delivery Devices Business

• 7.1 Phillips-Medisize
  • 7.1.1 Phillips-Medisize Connected Injectable Drug Delivery Devices Production Sites and Area Served
  • 7.1.2 Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
  • 7.1.3 Phillips-Medisize Connected Injectable Drug Delivery Devices Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 West Pharmaceutical Services
  • 7.2.1 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Production Sites and Area Served
  • 7.2.2 Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
  • 7.2.3 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Biocorp
  • 7.3.1 Biocorp Connected Injectable Drug Delivery Devices Production Sites and Area Served
  • 7.3.2 Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
  • 7.3.3 Biocorp Connected Injectable Drug Delivery Devices Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Aterica
  • 7.4.1 Aterica Connected Injectable Drug Delivery Devices Production Sites and Area Served
  • 7.4.2 Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
  • 7.4.3 Aterica Connected Injectable Drug Delivery Devices Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Unilife
  • 7.5.1 Unilife Connected Injectable Drug Delivery Devices Production Sites and Area Served
  • 7.5.2 Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
  • 7.5.3 Unilife Connected Injectable Drug Delivery Devices Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Propeller Health
  • 7.6.1 Propeller Health Connected Injectable Drug Delivery Devices Production Sites and Area Served
  • 7.6.2 Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
  • 7.6.3 Propeller Health Connected Injectable Drug Delivery Devices Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Haselmeier
  • 7.7.1 Haselmeier Connected Injectable Drug Delivery Devices Production Sites and Area Served
  • 7.7.2 Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
  • 7.7.3 Haselmeier Connected Injectable Drug Delivery Devices Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 SHL
  • 7.8.1 SHL Connected Injectable Drug Delivery Devices Production Sites and Area Served
  • 7.8.2 Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
  • 7.8.3 SHL Connected Injectable Drug Delivery Devices Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Becton Dickinson
  • 7.9.1 Becton Dickinson Connected Injectable Drug Delivery Devices Production Sites and Area Served
  • 7.9.2 Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
  • 7.9.3 Becton Dickinson Connected Injectable Drug Delivery Devices Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Baxter International
  • 7.10.1 Baxter International Connected Injectable Drug Delivery Devices Production Sites and Area Served
  • 7.10.2 Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
  • 7.10.3 Baxter International Connected Injectable Drug Delivery Devices Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Scandinavian Health
• 7.12 Ypsomed
• 7.13 Terumo Medical
• 7.14 Schott
• 7.15 Owen Mumford
• 7.16 Antares Pharma
• 7.17 Zogenix

8 Connected Injectable Drug Delivery Devices Manufacturing Cost Analysis

• 8.1 Connected Injectable Drug Delivery Devices Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Connected Injectable Drug Delivery Devices
• 8.4 Connected Injectable Drug Delivery Devices Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Connected Injectable Drug Delivery Devices Distributors List
• 9.3 Connected Injectable Drug Delivery Devices Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Connected Injectable Drug Delivery Devices Market Forecast

• 11.1 Global Connected Injectable Drug Delivery Devices Production, Revenue Forecast
  • 11.1.1 Global Connected Injectable Drug Delivery Devices Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Connected Injectable Drug Delivery Devices Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Connected Injectable Drug Delivery Devices Price and Trend Forecast (2019-2025)
• 11.2 Global Connected Injectable Drug Delivery Devices Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Connected Injectable Drug Delivery Devices Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Connected Injectable Drug Delivery Devices Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Connected Injectable Drug Delivery Devices Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Connected Injectable Drug Delivery Devices Production, Revenue Forecast (2019-2025)
• 11.3 Global Connected Injectable Drug Delivery Devices Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Connected Injectable Drug Delivery Devices Consumption Forecast (2019-2025)
  • 11.3.2 Europe Connected Injectable Drug Delivery Devices Consumption Forecast (2019-2025)
  • 11.3.3 China Connected Injectable Drug Delivery Devices Consumption Forecast (2019-2025)
  • 11.3.4 Japan Connected Injectable Drug Delivery Devices Consumption Forecast (2019-2025)
• 11.4 Global Connected Injectable Drug Delivery Devices Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Connected Injectable Drug Delivery Devices Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List